Key Account Manager
Arrowhead Pharmaceuticals
June 29, 2026
On-site
Los Angeles, CA
Sales
Responsibilities:
- Develop and execute comprehensive account strategies across priority IDNs, health systems, and complex accounts within an assigned geography.
- Build institutional access through formulary engagement, protocol development, and clinical pathway integration.
- Drive integration of Plozasiran into treatment algorithms, order sets, and clinical workflows with key institutional decision-makers.
- Own multi-year account growth plans, including system-level partnership development and sustained execution.
- Use adoption, access, and performance data to segment/prioritize accounts and identify high-impact opportunities and barriers.
- Monitor adoption metrics and address access barriers to accelerate pull-through.
- Maintain account planning discipline, including regular business reviews and updated stakeholder maps.
- Build trusted relationships with pharmacy leadership, population health leaders, value analysis committees, and clinical champions.
- Engage compliantly in value-based discussions (HEOR, outcomes, RWE) tailored to institutional priorities.
- Ensure alignment between enterprise decision-makers and field prescriber activation.
- Navigate multi-layered institutional approvals with strategic agility.
- Develop clinical fluency in FCS/ApoC-III biology and the evidence base for Plozasiran; educate stakeholders on disease prevalence, diagnostics, and patient identification.
- Collaborate with Health IT for patient identification tools/workflow integration.
- Partner with Rare Disease Specialists and Regional Sales Directors; collaborate with Market Access, Marketing, Medical Affairs, and Commercial Operations.
- Provide field insights on competitive dynamics, formulary positioning, and access trends.
- Own account performance/adoption objectives; monitor forecasting and growth indicators; maintain CRM documentation/reporting standards.
- Conduct enterprise engagements in compliance with applicable laws/regulations and ethical standards.
Experience/Qualifications:
- 5+ years of pharmaceutical/biotech experience (required).
- Experience in IDN, health system, or complex account management (required).
- Demonstrated ability to navigate/influence formulary, protocol, or pathway decisions.
- Track record of consistent performance and territory growth in a field-based commercial role.
- Specialty, rare disease, or cardiometabolic therapeutic experience preferred.
Skills & Competencies:
- Strong executive presence; advanced enterprise planning and account management.
- Understanding of health system economics, reimbursement, and access pathways.
- Ability to translate clinical/HEOR data into audience-appropriate value narratives.
- Analytical, data-driven prioritization; resilience and sound judgment.
- Collaborative cross-functional, cross-geography mindset; exceptional communication, negotiation, and stakeholder navigation.
Benefits/Compensation:
- Competitive base salary: $190,000–$210,000 plus incentive compensation.
- Equity (RSUs) eligibility; car allowance program.
- Comprehensive benefits: health, dental, vision, and 401(k).
- Develop and execute comprehensive account strategies across priority IDNs, health systems, and complex accounts within an assigned geography.
- Build institutional access through formulary engagement, protocol development, and clinical pathway integration.
- Drive integration of Plozasiran into treatment algorithms, order sets, and clinical workflows with key institutional decision-makers.
- Own multi-year account growth plans, including system-level partnership development and sustained execution.
- Use adoption, access, and performance data to segment/prioritize accounts and identify high-impact opportunities and barriers.
- Monitor adoption metrics and address access barriers to accelerate pull-through.
- Maintain account planning discipline, including regular business reviews and updated stakeholder maps.
- Build trusted relationships with pharmacy leadership, population health leaders, value analysis committees, and clinical champions.
- Engage compliantly in value-based discussions (HEOR, outcomes, RWE) tailored to institutional priorities.
- Ensure alignment between enterprise decision-makers and field prescriber activation.
- Navigate multi-layered institutional approvals with strategic agility.
- Develop clinical fluency in FCS/ApoC-III biology and the evidence base for Plozasiran; educate stakeholders on disease prevalence, diagnostics, and patient identification.
- Collaborate with Health IT for patient identification tools/workflow integration.
- Partner with Rare Disease Specialists and Regional Sales Directors; collaborate with Market Access, Marketing, Medical Affairs, and Commercial Operations.
- Provide field insights on competitive dynamics, formulary positioning, and access trends.
- Own account performance/adoption objectives; monitor forecasting and growth indicators; maintain CRM documentation/reporting standards.
- Conduct enterprise engagements in compliance with applicable laws/regulations and ethical standards.
Experience/Qualifications:
- 5+ years of pharmaceutical/biotech experience (required).
- Experience in IDN, health system, or complex account management (required).
- Demonstrated ability to navigate/influence formulary, protocol, or pathway decisions.
- Track record of consistent performance and territory growth in a field-based commercial role.
- Specialty, rare disease, or cardiometabolic therapeutic experience preferred.
Skills & Competencies:
- Strong executive presence; advanced enterprise planning and account management.
- Understanding of health system economics, reimbursement, and access pathways.
- Ability to translate clinical/HEOR data into audience-appropriate value narratives.
- Analytical, data-driven prioritization; resilience and sound judgment.
- Collaborative cross-functional, cross-geography mindset; exceptional communication, negotiation, and stakeholder navigation.
Benefits/Compensation:
- Competitive base salary: $190,000–$210,000 plus incentive compensation.
- Equity (RSUs) eligibility; car allowance program.
- Comprehensive benefits: health, dental, vision, and 401(k).